Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons-Reference-Cited by-同舟云学术

Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons

Published:2009-08 Issue: Volume:1286 Page:192-200
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Chen Li,Zhang Qiao Jun,Liu Jian,Wang Shuang,Ali Umar,Gui Zhen Hua,Wang Yong

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference53 articles.

1. Excitation of rat subthalamic nucleus neurones in vitro by activation of a group I metabotropic glutamate receptor;Abbott;Brain Res.,1997

2. Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP;Aguirre;Brain Res.,2005

3. Inhibition of nigral dopamine neurons by systemic and local apomorphine: possible contribution of dendritic autoreceptors;Akaoka;Neuroscience,1992

4. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus;Awad;J. Neurosci.,2000

5. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism;Bergman;J. Neurophysiol.,1994

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration;2024-07-26

2. Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration;2024-07-26

3. Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration;2024-04-10

4. Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression;Experimental Neurology;2024-04

5. Role of dopamine neuron activity in Parkinson's disease pathophysiology;Experimental Neurology;2024-03